Literature DB >> 9374751

Cardiorenal epinephrine kinetics: evidence for neuronal release in the human heart.

M Johansson1, B Rundqvist, G Eisenhofer, P Friberg.   

Abstract

There are experimental data suggesting that epinephrine (Epi) may act as a cotransmitter in sympathetic nerves, stimulating presynaptic beta 2-receptors and enhancing norepinephrine (NE) release. To examine neuronal Epi release, patients with congestive heart failure and hypertension and healthy subjects were examined with the isotope-dilution method. At baseline, small cardiac and renal Epi spillovers were found in patients. During intense supine exercise, cardiac NE and Epi spillovers increased concomitantly with similar magnitude, whereas no renal Epi spillover could be detected. Blockade of neuronal uptake 1 caused a consistent decrease in both cardiac and renal fractional extractions of NE and Epi. The present study demonstrates baseline cardiorenal Epi release in patients with congestive heart failure and renal Epi release in hypertensive patients. Furthermore, Epi is removed by neuronal uptake in both the heart and kidney, and cardiac Epi spillover increases during exercise. This study, in contrast to other results, provides evidence for cardiac neuronal Epi release.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374751     DOI: 10.1152/ajpheart.1997.273.5.H2178

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Plasma catecholamines and ischemic heart disease.

Authors:  Jana Slavíková; Jitka Kuncová; Ondrej Topolcan
Journal:  Clin Cardiol       Date:  2007-07       Impact factor: 2.882

Review 2.  Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics.

Authors:  M Esler; D Kaye
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

Review 3.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

4.  Impact of cardiovascular comorbidity on ovarian cancer mortality.

Authors:  Eileen H Shinn; Daniel J Lenihan; Diana L Urbauer; Karen M Basen-Engquist; Alan Valentine; Laura Palmero; Myrshia L Woods; Pooja Patel; Alpa M Nick; Mian M K Shahzad; Rebecca L Stone; Antoinette Golden; Emma Atkinson; Susan K Lutgendorf; Anil K Sood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.